Antonicelli R, Andreoni A, Saccomanno G, Gambini C, Paciaroni E
Centre for Cardiovascular Disease and Arterial Hypertension, Institute INRCA, Ancona, Italy.
Drugs Exp Clin Res. 1989;15(11-12):577-81.
Sixty patients, with mild to moderate essential hypertension, were considered for a double-blind trial comparing the effects of ketanserin and atenolol. After 2 weeks of placebo, a group of 30 patients was given ketanserin 20 mg twice daily for 15 days and 40 mg twice daily for the subsequent 45 days, while the second group (30 patients) was given atenolol for 60 days at the dose of 100 mg once daily. Blood pressure and pulse rate in the supine and standing positions were evaluated every 15 days. After the beginning of treatment with ketanserin, there was a gradual but highly significant decrease of the diastolic and systolic blood pressure values. No important side-effects or significant alterations in the biochemical parameters considered were observed during treatment with ketanserin.
60名轻至中度原发性高血压患者被纳入一项双盲试验,比较酮色林和阿替洛尔的疗效。经过2周的安慰剂治疗后,一组30名患者每日两次服用20mg酮色林,持续15天,随后45天每日两次服用40mg;而第二组(30名患者)每日一次服用100mg阿替洛尔,持续60天。每15天评估仰卧位和站立位的血压及脉搏率。开始使用酮色林治疗后,舒张压和收缩压值逐渐但显著下降。在使用酮色林治疗期间,未观察到重要的副作用或所考虑的生化参数有显著改变。